MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Muscle-Weakening disease: experimental drug enters Mid-Stage testing
Disease control OngoingThis study is testing an experimental drug called DNTH103 for adults with generalized myasthenia gravis, a condition that causes muscle weakness. The trial will enroll 65 participants to compare the drug against a placebo over 13 weeks, measuring safety and whether it improves da…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New drug trial aims to control debilitating muscle disease
Disease control OngoingThis study is testing whether an intravenous drug called efgartigimod is effective and safe for adults with a specific, hard-to-treat form of generalized myasthenia Gravis (gMG). About 119 participants will be randomly assigned to receive either the drug or a placebo for part of …
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC